Aoxing Pharmaceutical Company Inc.
AXN
AXN was delisted on the 16th of October, 2017.
3 hedge funds and large institutions have $11K invested in Aoxing Pharmaceutical Company Inc. in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
25% less funds holding
Funds holding: 4 → 3 (-1)
84% less capital invested
Capital invested by funds: $67K → $11K (-$56K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$4.38K |
AXN Hedge Fund Activity: Q4 2014 in Review
3 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Aoxing Pharmaceutical Company Inc. (AXN) for Q4 2014, worth a combined $11K — down 84% from $67K a quarter earlier.
Fund positioning in AXN was balanced in Q4 2014: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Citadel Advisors, cutting an estimated $4.38K.
- 3 institutional investors held Aoxing Pharmaceutical Company Inc. (AXN) as of Q4 2014, down from 4 in Q3 2014.
- Funds reported $11K of Aoxing Pharmaceutical Company Inc. stock for Q4 2014, down 84% quarter-over-quarter.
- 1 fund opened new Aoxing Pharmaceutical Company Inc. positions in Q4 2014 and 1 closed out, a net change of 0 holders.
- The largest Aoxing Pharmaceutical Company Inc. seller in Q4 2014 was Citadel Advisors, an estimated $4.38K sold.
Based on aggregated 13F filings for Q4 2014.